Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2025)
Verastem (VSTM) recorded quarterly Depreciation & Amortization (CF) of $18000.0 in Q4 2025, up 800.0% quarter-over-quarter from $2000.0 in Q3 2025, and up 157.14% on a YoY basis from $7000.0 in Q4 2024.
Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Verastem's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) rose 157.14% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $20000.0 (down 31.03% YoY), while the FY2025 annual figure was $30000.0, up 15.38% from the prior year.
- Depreciation & Amortization (CF) was $18000.0 for Q4 2025 at Verastem, up from $2000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $81000.0 in Q1 2021 to a low of $2000.0 in Q3 2025.
- Historically, Depreciation & Amortization (CF) has averaged $22263.2 across 5 years, with a median of $18000.0 in 2025.
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) sank 88.51% in 2021, then surged 157.14% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $30000.0 in 2021, then sank by 63.33% to $11000.0 in 2022, then tumbled by 54.55% to $5000.0 in 2023, then surged by 40.0% to $7000.0 in 2024, then soared by 157.14% to $18000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $18000.0 (Q4 2025), $2000.0 (Q3 2025), and $10000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |